AstraZeneca is seeking regulatory approval for new products, while analysts are tracking how these developments affect stock valuation.

The entities involved

• AstraZeneca →

  company in Osaka, Japan

  Nothing else this week.

• FDA →
  • Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
  • A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56
• Morgan Stanley →

  U.S. investment bank

  • Financial firms including Morgan Stanley, Truist Financial, Jefferies Financial Group, and CIBC issued rating and price objective updates for Clearway Energy.Mon 17:33
  • Goldman Sachs, Morgan Stanley, JPMorgan Chase, and Bank of America are competing in the global investment banking sector.Mon 17:24

Related events

• Mylan is seeking regulatory approval from the FDA for new products and has listed its stock on the Nasdaq exchange.Sep 2
• The FDA and Intellia Therapeutics are preparing a regulatory filing for product approval.Jun 24